Ten yr of pediatric heart transplantation: A report from the Pediatric Heart Transplant Study

Pediatric Transplantation

Volumn 17, Issue 2, 2013, Pages 99-111

  Dipchand, Anne I ^a   Kirk, Richard ^b   Mahle, William T ^c   Tresler, Margaret A ^d   Naftel, David C ^d   Pahl, Elfriede ^e   Miyamoto, Shelley D ^f   Blume, Elizabeth ^g   Guleserian, Kristine J ^h   White Williams, Connie ^d   Kirklin, James K ^d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b FREEMAN HOSPITAL   (United Kingdom)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e CHILDREN'S MEMORIAL HOSPITAL   (United States)

^f CHILDREN S HOSPITAL   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h CHILDREN S MEDICAL CENTER   (United States)

Author keywords

heart transplant; outcomes; pediatric; registry report; risk factors

Indexed keywords

GLUCAGON; HLA ANTIBODY; VASOPRESSIN;

ASPERGILLOSIS; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; COLD ISCHEMIA; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; EXTRACORPOREAL CIRCULATION; FONTAN PROCEDURE; GENETIC POLYMORPHISM; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT INFECTION; GRAFT SURVIVAL; HEART GRAFT; HEART HEMODYNAMICS; HEART INFARCTION; HEART TRANSPLANTATION; HIGH RISK PATIENT; HORMONAL THERAPY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOPLASTIC LEFT HEART SYNDROME; INCIDENCE; ORGAN DONOR; OVERALL SURVIVAL; PNEUMOCYSTOSIS; POSTOPERATIVE PERIOD; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PROPHYLAXIS; RESTRICTIVE CARDIOMYOPATHY; RETRANSPLANTATION; REVIEW; RISK FACTOR; SUDDEN DEATH; SURGICAL MORTALITY; TREATMENT INDICATION; TREATMENT OUTCOME; VENTRICULAR ASSIST DEVICE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HEART TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MULTICENTER STUDIES AS TOPIC; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; REGISTRIES; TISSUE DONORS; UNITED STATES; WAITING LISTS;

EID: 84874485155     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12038     Document Type: Review

References (48)

1. Kirk R, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Heart Transplantation Report-2011. J Heart Lung Transplant 2011: 30: 1095-1103.
2. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI,. Registry of the International Society of Heart and Lung Transplantation: Eighth Official Pediatric Report-2005. J Heart Lung Transplant 2005: 24: 968-982. (Pubitemid 41127176)
3. Kaye MP,. Pediatric thoracic transplantation: The world experience. J Heart Lung Transplant 1993: 12 (6 Pt 2): S344-S350. (Pubitemid 24018968)
4. Kaye MP, Elcombe SA, O'Fallon WM,. The international heart transplant registry: The 1984 Report. J Heart Transplant 1985: 4: 290-292.
5. Almond CS, Singh TP, Gauvreau K, et al. Extracorporeal membrane oxygenation for bridge to heart transplantation among children in the United States: Analysis of data from the organ procurement and transplant network and extracorporeal life support organization registry. Circulation 2011: 123: 2975-2984.
6. Patel ND, Weiss ES, Scheel J, Cameron DE, Vricella LA,. ABO-incompatible heart transplantation in infants: Analysis of the united network for organ sharing database. J Heart Lung Transplant 2008: 27: 1085-1089.
7. Singh TP, Naftel DC, Addonizio L, et al. Association of race and socioeconomic position with outcomes in pediatric heart transplant recipients. Am J Transplant 2010: 10: 2116-2123.
8. Hsu DT, Naftel DC, Webber SA, et al. Lessons learned from the pediatric heart transplant study. Congenit Heart Dis 2006: 1: 54-62. (Pubitemid 43805646)
9. McGiffin DC, Naftel DC, Kirklin JK, et al. Predicting outcome after listing for heart transplantation in children: Comparison of Kaplan-Meier and parametric competing risk analysis. J Heart Lung Transplant 1997: 16: 713-722. (Pubitemid 27319147)
10. Blackstone EH, Naftel DC, Turner ME,. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 1986: 81: 615-624.
11. Kirklin JK, Naftel DC, Caldwell RL, et al. Should status II patients be removed from the pediatric heart transplant waiting list? A multi-institutional study. J Heart Lung Transplant 2006: 25: 271-275. (Pubitemid 43290655)
12. Larsen RL, Canter CE, Naftel DC, et al. The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy. J Heart Lung Transplant 2011: 30: 755-760.
13. Dipchand AI, Naftel DC, Feingold B, et al. Outcomes of children with cardiomyopathy listed for transplant: A multi-institutional study. J Heart Lung Transplant 2009: 28: 1312-1321.
14. Everitt MD, Boyle GJ, Schechtman KB, et al. Early survival after heart transplant in young infants is lowest after failed single-ventricle palliation: A multi-institutional study. J Heart Lung Transplant 2012: 31: 509-516.
15. Gajarski R, Naftel DC, Pahl E, et al. Outcomes of pediatric patients with hypertrophic cardiomyopathy listed for transplant. J Heart Lung Transplant 2009: 28: 1329-1334.
16. Guleserian KJ, Schechtman KB, Zheng J, et al. Outcomes after listing for primary transplantation for infants with unoperated-on non-hypoplastic left heart syndrome congenital heart disease: A multi-institutional study. J Heart Lung Transplant 2011: 30: 1023-1032.
17. Zangwill SD, Naftel D, L'Ecuyer T, et al. Outcomes of children with restrictive cardiomyopathy listed for heart transplant: A multi-institutional study. J Heart Lung Transplant 2009: 28: 1335-1340.
18. Dipchand AI, Mahle W, Tresler M, et al. Extracorporeal membrane oxygenation as a bridge to pediatric heart transplantation: impact on post-listing and post-transplantation outcomes (abstract). Circulation 2011: 124 (21 Suppl 1): A16269.
19. Conway J, Chin C, Kemma M, et al. Donor characteristics and impact on outcomes in pediatric heart transplant recipients (abstract). J Heart Lung Transplant 2011: 30 (4 Suppl 1): S133.
20. Kirk R, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: Thirteenth Official Pediatric Heart Transplantation Report-2010. J Heart Lung Transplant 2010: 29: 1119-1128.
21. Girnita DM, Brooks MM, Webber SA, et al. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: A multi-institutional study. Transplantation 2008: 85: 1632-1639.
22. Girnita DM, Ohmann EL, Brooks MM, et al. Gene polymorphisms impact the risk of rejection with hemodynamic compromise: A multicenter study. Transplantation 2011: 91: 1326-1332.
23. Feingold B, Zheng J, Law YM, et al. Risk factors for late renal dysfunction after pediatric heart transplantation: A multi-institutional study. Pediatr Transplant 2011: 15: 699-705.
24. George JF, Taylor DO, Blume ED, et al. Minimizing infection and rejection death: Clues acquired from 19 years of multi-institutional cardiac transplantation data. J Heart Lung Transplant 2011: 30: 151-157.
25. Daly KP, Chakravarti SB, Tresler M, et al. Sudden death after pediatric heart transplantation: Analysis of data from the Pediatric Heart Transplant Study Group. J Heart Lung Transplant 2011: 30: 1395-1402.
26. Henderson HT, Canter CE, Mahle WT, et al. ABO-incompatible heart transplantation: Analysis of the Pediatric Heart Transplant Study (PHTS) database. J Heart Lung Transplant 2011: 31: 173-179.
27. Mahle WT, Tresler MA, Edens RE, et al. Allosensitization and outcomes in pediatric heart transplantation. J Heart Lung Transplant 2011: 30: 1221-1227.
28. Alsoufi B, Al-Radi OO, Gruenwald C, et al. Extra-corporeal life support following cardiac surgery in children: Analysis of risk factors and survival in a single institution. Eur J Cardiothorac Surg 2009: 35: 1004-1011.
29. Pollock-BarZiv SM, McCrindle BW, West LJ, et al. Outcomes of pediatric patients bridged to heart transplantation from extracorporeal membrane oxygenation support. ASAIO J 2007: 53: 97-102. (Pubitemid 46145497)
30. Blume ED, Naftel DC, Bastardi HJ, Duncan BW, Kirklin JK, Webber SA,. Outcomes of children bridged to heart transplantation with ventricular assist devices: A multi-institutional study. Circulation 2006: 113: 2313-2319. (Pubitemid 43947977)
31. Kirk R, Naftel D, Hoffman TM, et al. Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: A multi-institutional study. J Heart Lung Transplant 2009: 28: 1322-1328.
32. Pietra BA, Kantor PF, Bartlett HL, et al. Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation 2012: 126: 1079-1086.
33. Gandhi R, Almond C, Singh TP, Gauvreau K, Piercey G, Thiagarajan RR,. Factors associated with in-hospital mortality in infants undergoing heart transplantation in the United States. J Thorac Cardiovasc Surg 2011: 141: 531-536.
34. Bernstein D, Naftel D, Chin C, et al. Outcome of listing for cardiac transplantation. Circulation 2006: 114: 273-280.
35. Kovach JR, Naftel DC, Pearce FB, et al. Comparison of risk factors and outcomes for pediatric patients listed for heart transplantation after bidirectional Glenn and after Fontan: An analysis of the Pediatric Heart Transplant Study. J Heart Lung Transplant 2012: 31: 133-139.
36. Ameduri RK, Zheng J, Schechtman KB, et al. Has late rejection decreased in pediatric heart transplantation in the current era? A multi-institutional study. J Heart Lung Transplant 2012: 31: 980-986.
37. Gossett JG, Canter CE, Zheng J, et al. Decline in rejection in the first year after pediatric cardiac transplantation: A multi-institutional study. J Heart Lung Transplant 2010: 29: 625-632.
38. Everitt MD, Pahl E, Schechtman KB, et al. Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: A multi-institutional study. J Heart Lung Transplant 2010: 30: 282-288.
39. Gajarski RJ, Blume ED, Urschel S, et al. Infection and malignancy after pediatric heart transplantation: The role of induction therapy. J Heart Lung Transplant 2011: 30: 299-308.
40. Mahle WT, Foushee MT, Naftel DC, et al. Does cytomegalovirus serology impact outcome after pediatric heart transplantation? J Heart Lung Transplant 2009: 28: 1299-1305.
41. Ng B, Dipchand A, Naftel D, et al. Outcomes of Pneumocystis jiroveci pneumonia infections in pediatric heart transplant recipients. Pediatr Transplant 2011: 15: 844-848.
42. Zaoutis TE, Webber S, Naftel DC, et al. Invasive fungal infections in pediatric heart transplant recipients: Incidence, risk factors, and outcomes. Pediatr Transplant 2011: 15: 465-469.
43. Webber SA, Naftel DC, Fricker FJ, et al. Lymphoproliferative disorders after pediatric heart transplantation: A multi-institutional study. Lancet 2006: 367: 233-239. (Pubitemid 43107668)
44. Chinnock R, Webber SA, Dipchand AI, Brown RN, George JF,. A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients. Am J Transplant 2012: 12: 3061-3068.
45. Jeewa A, Chin C, Pahl E, et al. Outcomes after percutaneous coronary artery revascularization procedures for allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional experience (abstract). J Heart Lung Transplant 2011: 30 (4S): S133.
46. Pahl E, Naftel DC, Kuhn MA, et al. The impact and outcome of transplant coronary artery disease in a pediatric population: A 9-year multi-institutional study. J Heart Lung Transplant 2005: 24: 645-651. (Pubitemid 40798245)
47. Mehra M, Crespo-Leiro MG, Dipchand A, et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant 2010: 29: 717-727.
48. Chin C, Naftel D, Pahl E, et al. Cardiac re-transplantation in pediatrics: A multi-institutional study. J Heart Lung Transplant 2006: 25: 1420-1424. (Pubitemid 44909468)